A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study

BACKGROUND: Cancer cachexia is a syndrome of progressive weight loss. Non-small cell lung cancer patients experience a high incidence of cachexia of 61%. Research into methods to combat cancer cachexia in various tumour sites has recently progressed to the combination of agents. The combination of t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Rogers, Elaine S, MacLeod, Roderick D, Stewart, Joanna, Bird, Stephen P, Keogh, Justin WL
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Study Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3252396/
https://ncbi.nlm.nih.gov/pubmed/22111896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-493
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker